About the Study

Are you looking to switch your medication?

This study is designed to evaluate the safety and effectiveness of switching medicine for clinically stable patients with schizophrenia by switching from one antipsychotic to SEP-363856.
This study is sponsored by Sunovion Pharmaceuticals Inc.

Length of Study:

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18 – 65 years old
• have a diagnosis of schizophrenia
• are currently taking an oral antipsychotic

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. 

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.